Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of Genetic Variations in APLN and APLNR Genes and Their Potential Role in Cardiovascular Diseases. | Rep Biochem Mol Biol | 2025 | 40842897 | PubTator, text mining | PubMed |
| Apelin as a CNS-specific pathway for fenestrated capillary formation in the choroid plexus. | Nat Commun | 2025 | 40830138 | PubTator, text mining | PubMed |
| Mechanistic insights into the versatile stoichiometry and biased signaling of the apelin receptor-arrestin complex. | Nat Commun | 2025 | 40790299 | PubTator, text mining | PubMed |
| Novel small molecule analogs for advancing apelin receptor antagonism with enhanced plasma and microsomal stability. | Bioorg Med Chem Lett | 2025 | 40784515 | PubTator, text mining | PubMed |
| Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis. | Front Cell Dev Biol | 2025 | 40761743 | PubTator, text mining | PubMed |
| Author Correction: In vivo measurement of an Apelin gradient with a genetically encoded APLNR conformation biosensor. | Nat Commun | 2025 | 40759638 | PubTator, text mining | PubMed |
| Uncovering plaque-glia niches in human Alzheimer's disease brains using spatial transcriptomics. | Mol Neurodegener Adv | 2025 | 40740481 | PubTator, text mining | PubMed |
| AI meets physics in computational structure-based drug discovery for GPCRs. | NPJ Drug Discov | 2025 | 40621551 | PubTator, text mining | PubMed |
| Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic system. | Eur J Pharmacol | 2025 | 40550349 | PubTator, text mining | PubMed |
| Apelin Alleviated Endothelial-To-Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy. | FASEB J | 2025 | 40536101 | PubTator, text mining | PubMed |
| Analysis of immune status and prognostic model incorporating lactate metabolism and immune-related genes in clear cell renal cell carcinoma. | Discov Oncol | 2025 | 40481935 | PubTator, text mining | PubMed |
| Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment. | Biomaterials | 2025 | 40449081 | PubTator, text mining | PubMed |
| Insights into the function and research status of membrane protein APJ. | Gene | 2025 | 40419033 | PubTator, text mining | PubMed |
| Immunohistochemistry and molecular biology studies of apelin and apelin receptor in queen placenta. | Vet Res Commun | 2025 | 40392420 | PubTator, text mining | PubMed |
| CD157+ vascular endothelial cells derived from human-induced pluripotent stem cells have high angiogenic potential. | Inflamm Regen | 2025 | 40369638 | PubTator, text mining | PubMed |
| Therapeutic angiogenesis mediated by traditional Chinese Medicine: Advances in cardiovascular disease treatment. | J Ethnopharmacol | 2025 | 40345269 | PubTator, text mining | PubMed |
| Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy. | Proc Natl Acad Sci U S A | 2025 | 40314976 | PubTator, text mining | PubMed |
| Assessment of Levels of Apelinergic System Peptides in Serum and Epicardial Adipose Tissue in Patients with Multivessel Coronary Artery Disease Who Underwent Myocardial Revascularisation. | Biomedicines | 2025 | 40299338 | PubTator, text mining | PubMed |
| Apelinergic System in the Left Ventricle Adverse Remodeling After Myocardial Infarction: A Preliminary Study. | Vasc Health Risk Manag | 2025 | 40297796 | PubTator, text mining | PubMed |
| Apelin/APJ: Another Player in the Cancer Biology Network. | Int J Mol Sci | 2025 | 40243599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=5